Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ubiquitin carboxyl-terminal hydrolase 9Y (USP9Y) is an enzyme encoded by the USP9Y gene located in the azoospermia factor (AZF) region on the Y chromosome. It is a member of the peptidase C19 family and functions as a deubiquitinase that cleaves the ubiquitin moiety from ubiquitin-fused precursors and ubiquitinylated proteins, playing a critical role in protein homeostasis and stabilization. USP9Y has an essential role in normal spermatogenesis, with mutations linked to male infertility and Sertoli cell-only syndrome. Although some individuals can remain fertile despite USP9Y deletions, it is generally considered necessary for optimal sperm production. USP9Y is testis-specific in expression and homologous to the X-linked USP9X.
No therapeutic drugs targeting USP9Y are described; therefore, mechanism of action is not established. Its enzymatic activity relates to the removal of ubiquitin from target proteins.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ubiquitin carboxyl-terminal hydrolase 9Y (USP9Y).